Logo image of SYENS.BR

SYENSQO SA (SYENS.BR) Stock Fundamental Analysis

Europe - EBR:SYENS - BE0974464977 - Common Stock

69.3 EUR
-0.26 (-0.37%)
Last: 10/21/2025, 10:02:35 AM
Fundamental Rating

4

SYENS gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 66 industry peers in the Chemicals industry. Both the profitability and the financial health of SYENS get a neutral evaluation. Nothing too spectacular is happening here. SYENS has a valuation in line with the averages, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

In the past year SYENS was profitable.
SYENS had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: SYENS reported negative net income in multiple years.
In the past 5 years SYENS always reported a positive cash flow from operatings.
SYENS.BR Yearly Net Income VS EBIT VS OCF VS FCFSYENS.BR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 0 500M -500M 1B -1B

1.2 Ratios

Looking at the Return On Assets, with a value of -0.71%, SYENS is doing worse than 60.61% of the companies in the same industry.
SYENS has a worse Return On Equity (-1.30%) than 60.61% of its industry peers.
SYENS has a Return On Invested Capital of 4.38%. This is comparable to the rest of the industry: SYENS outperforms 59.09% of its industry peers.
The Average Return On Invested Capital over the past 3 years for SYENS is in line with the industry average of 7.02%.
The last Return On Invested Capital (4.38%) for SYENS is well below the 3 year average (8.47%), which needs to be investigated, but indicates that SYENS had better years and this may not be a problem.
Industry RankSector Rank
ROA -0.71%
ROE -1.3%
ROIC 4.38%
ROA(3y)2.81%
ROA(5y)0.13%
ROE(3y)7.26%
ROE(5y)-1.97%
ROIC(3y)8.47%
ROIC(5y)7.63%
SYENS.BR Yearly ROA, ROE, ROICSYENS.BR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 -20 -40

1.3 Margins

SYENS has a Operating Margin of 9.25%. This is in the better half of the industry: SYENS outperforms 68.18% of its industry peers.
In the last couple of years the Operating Margin of SYENS has declined.
SYENS's Gross Margin of 31.11% is in line compared to the rest of the industry. SYENS outperforms 43.94% of its industry peers.
SYENS's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 9.25%
PM (TTM) N/A
GM 31.11%
OM growth 3Y-4.48%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.24%
GM growth 5YN/A
SYENS.BR Yearly Profit, Operating, Gross MarginsSYENS.BR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 0 10 -10 20 -20 30

5

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), SYENS is creating some value.
The number of shares outstanding for SYENS has been reduced compared to 1 year ago.
The debt/assets ratio for SYENS has been reduced compared to a year ago.
SYENS.BR Yearly Shares OutstandingSYENS.BR Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
SYENS.BR Yearly Total Debt VS Total AssetsSYENS.BR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.2 Solvency

SYENS has an Altman-Z score of 2.23. This is not the best score and indicates that SYENS is in the grey zone with still only limited risk for bankruptcy at the moment.
SYENS has a Altman-Z score (2.23) which is in line with its industry peers.
The Debt to FCF ratio of SYENS is 25.36, which is on the high side as it means it would take SYENS, 25.36 years of fcf income to pay off all of its debts.
SYENS has a Debt to FCF ratio (25.36) which is comparable to the rest of the industry.
A Debt/Equity ratio of 0.43 indicates that SYENS is not too dependend on debt financing.
SYENS's Debt to Equity ratio of 0.43 is in line compared to the rest of the industry. SYENS outperforms 51.52% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.43
Debt/FCF 25.36
Altman-Z 2.23
ROIC/WACC0.63
WACC6.93%
SYENS.BR Yearly LT Debt VS Equity VS FCFSYENS.BR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 2B 4B 6B

2.3 Liquidity

A Current Ratio of 2.27 indicates that SYENS has no problem at all paying its short term obligations.
SYENS's Current ratio of 2.27 is fine compared to the rest of the industry. SYENS outperforms 69.70% of its industry peers.
A Quick Ratio of 1.56 indicates that SYENS should not have too much problems paying its short term obligations.
The Quick ratio of SYENS (1.56) is better than 74.24% of its industry peers.
Industry RankSector Rank
Current Ratio 2.27
Quick Ratio 1.56
SYENS.BR Yearly Current Assets VS Current LiabilitesSYENS.BR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

2

3. Growth

3.1 Past

SYENS shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -102.63%.
SYENS shows a decrease in Revenue. In the last year, the revenue decreased by -3.10%.
Measured over the past years, SYENS shows a small growth in Revenue. The Revenue has been growing by 4.31% on average per year.
EPS 1Y (TTM)-102.63%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-67.55%
Revenue 1Y (TTM)-3.1%
Revenue growth 3Y4.31%
Revenue growth 5YN/A
Sales Q2Q%-7.14%

3.2 Future

SYENS is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 9.07% yearly.
The Revenue is expected to grow by 2.15% on average over the next years.
EPS Next Y-7.21%
EPS Next 2Y5.29%
EPS Next 3Y8.84%
EPS Next 5Y9.07%
Revenue Next Year-2.87%
Revenue Next 2Y0.51%
Revenue Next 3Y1.82%
Revenue Next 5Y2.15%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
SYENS.BR Yearly Revenue VS EstimatesSYENS.BR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2B 4B 6B 8B
SYENS.BR Yearly EPS VS EstimatesSYENS.BR Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2025 2026 2027 2028 2029 2030 2 4 6 8

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 18.58, which indicates a rather expensive current valuation of SYENS.
Based on the Price/Earnings ratio, SYENS is valued a bit cheaper than 62.12% of the companies in the same industry.
When comparing the Price/Earnings ratio of SYENS to the average of the S&P500 Index (27.69), we can say SYENS is valued slightly cheaper.
Based on the Price/Forward Earnings ratio of 11.86, the valuation of SYENS can be described as reasonable.
Based on the Price/Forward Earnings ratio, SYENS is valued cheaper than 80.30% of the companies in the same industry.
SYENS is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 23.18, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 18.58
Fwd PE 11.86
SYENS.BR Price Earnings VS Forward Price EarningsSYENS.BR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

72.73% of the companies in the same industry are more expensive than SYENS, based on the Enterprise Value to EBITDA ratio.
The rest of the industry has a similar Price/Free Cash Flow ratio as SYENS.
Industry RankSector Rank
P/FCF 59.52
EV/EBITDA 6.6
SYENS.BR Per share dataSYENS.BR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y5.29%
EPS Next 3Y8.84%

1

5. Dividend

5.1 Amount

SYENS has a Yearly Dividend Yield of 1.69%.
SYENS's Dividend Yield is comparable with the industry average which is at 3.14.
SYENS's Dividend Yield is slightly below the S&P500 average, which is at 2.34.
Industry RankSector Rank
Dividend Yield 1.69%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years1
SYENS.BR Yearly Dividends per shareSYENS.BR Yearly Dividends per shareYearly Dividends per share 2024 2025 0.5 1 1.5

5.3 Sustainability

The earnings of SYENS are negative and hence is the payout ratio. SYENS will probably not be able to sustain this dividend level.
DP-210.34%
EPS Next 2Y5.29%
EPS Next 3Y8.84%
SYENS.BR Yearly Income VS Free CF VS DividendSYENS.BR Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2020 2021 2022 2023 2024 0 500M -500M -1B

SYENSQO SA

EBR:SYENS (10/21/2025, 10:02:35 AM)

69.3

-0.26 (-0.37%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)07-31 2025-07-31/dmh
Earnings (Next)11-06 2025-11-06
Inst Owners28.34%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap7.20B
Analysts79.29
Price Target84.05 (21.28%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.69%
Yearly Dividend1.63
Dividend Growth(5Y)N/A
DP-210.34%
Div Incr Years0
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-31.92%
Min EPS beat(2)-59.05%
Max EPS beat(2)-4.8%
EPS beat(4)0
Avg EPS beat(4)-27.51%
Min EPS beat(4)-59.05%
Max EPS beat(4)-4.8%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-3.4%
Min Revenue beat(2)-4.63%
Max Revenue beat(2)-2.18%
Revenue beat(4)0
Avg Revenue beat(4)-3.18%
Min Revenue beat(4)-4.63%
Max Revenue beat(4)-1.3%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0.36%
PT rev (3m)-0.19%
EPS NQ rev (1m)-7.18%
EPS NQ rev (3m)-12.57%
EPS NY rev (1m)0%
EPS NY rev (3m)-13.1%
Revenue NQ rev (1m)-1.25%
Revenue NQ rev (3m)-4.74%
Revenue NY rev (1m)-0.14%
Revenue NY rev (3m)-4.05%
Valuation
Industry RankSector Rank
PE 18.58
Fwd PE 11.86
P/S 1.08
P/FCF 59.52
P/OCF 9.62
P/B 1.08
P/tB 2.59
EV/EBITDA 6.6
EPS(TTM)3.73
EY5.38%
EPS(NY)5.84
Fwd EY8.43%
FCF(TTM)1.16
FCFY1.68%
OCF(TTM)7.21
OCFY10.4%
SpS64.16
BVpS64.4
TBVpS26.71
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.71%
ROE -1.3%
ROCE 5.83%
ROIC 4.38%
ROICexc 5%
ROICexgc 8.66%
OM 9.25%
PM (TTM) N/A
GM 31.11%
FCFM 1.81%
ROA(3y)2.81%
ROA(5y)0.13%
ROE(3y)7.26%
ROE(5y)-1.97%
ROIC(3y)8.47%
ROIC(5y)7.63%
ROICexc(3y)9.08%
ROICexc(5y)8.08%
ROICexgc(3y)19%
ROICexgc(5y)18.92%
ROCE(3y)11.29%
ROCE(5y)10.17%
ROICexcg growth 3Y-19.3%
ROICexcg growth 5YN/A
ROICexc growth 3Y-9.3%
ROICexc growth 5YN/A
OM growth 3Y-4.48%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.24%
GM growth 5YN/A
F-Score4
Asset Turnover0.54
Health
Industry RankSector Rank
Debt/Equity 0.43
Debt/FCF 25.36
Debt/EBITDA 2.11
Cap/Depr 84.98%
Cap/Sales 9.42%
Interest Coverage 250
Cash Conversion 55.24%
Profit Quality N/A
Current Ratio 2.27
Quick Ratio 1.56
Altman-Z 2.23
F-Score4
WACC6.93%
ROIC/WACC0.63
Cap/Depr(3y)98.43%
Cap/Depr(5y)76.05%
Cap/Sales(3y)9.47%
Cap/Sales(5y)8.2%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-102.63%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-67.55%
EPS Next Y-7.21%
EPS Next 2Y5.29%
EPS Next 3Y8.84%
EPS Next 5Y9.07%
Revenue 1Y (TTM)-3.1%
Revenue growth 3Y4.31%
Revenue growth 5YN/A
Sales Q2Q%-7.14%
Revenue Next Year-2.87%
Revenue Next 2Y0.51%
Revenue Next 3Y1.82%
Revenue Next 5Y2.15%
EBIT growth 1Y-33.42%
EBIT growth 3Y-0.36%
EBIT growth 5YN/A
EBIT Next Year43.66%
EBIT Next 3Y19.94%
EBIT Next 5Y15.16%
FCF growth 1Y-85.81%
FCF growth 3Y-7.48%
FCF growth 5YN/A
OCF growth 1Y-52.53%
OCF growth 3Y7.55%
OCF growth 5YN/A